Innoviva Inc (INVA)
16.08
-0.07
(-0.43%)
USD |
NASDAQ |
May 22, 16:00
16.05
-0.03
(-0.19%)
Pre-Market: 20:00
Innoviva Cash from Financing (Quarterly): -9.165M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -9.165M |
| December 31, 2023 | -14.59M |
| September 30, 2023 | -11.08M |
| June 30, 2023 | -9.206M |
| March 31, 2023 | -136.96M |
| December 31, 2022 | -10.00M |
| September 30, 2022 | -96.16M |
| June 30, 2022 | -9.735M |
| March 31, 2022 | 60.33M |
| December 31, 2021 | -12.07M |
| September 30, 2021 | -4.861M |
| June 30, 2021 | -414.26M |
| March 31, 2021 | -21.31M |
| December 31, 2020 | -2.505M |
| September 30, 2020 | -0.012M |
| June 30, 2020 | -11.63M |
| March 31, 2020 | -15.64M |
| December 31, 2019 | -13.75M |
| September 30, 2019 | -10.47M |
| June 30, 2019 | 0.198M |
| March 31, 2019 | 0.246M |
| December 31, 2018 | -2.381M |
| September 30, 2018 | -112.25M |
| June 30, 2018 | -0.715M |
| March 31, 2018 | -122.62M |
| Date | Value |
|---|---|
| December 31, 2017 | -87.06M |
| September 30, 2017 | -10.93M |
| June 30, 2017 | -56.84M |
| March 31, 2017 | -8.364M |
| December 31, 2016 | -19.58M |
| September 30, 2016 | -24.84M |
| June 30, 2016 | -26.80M |
| March 31, 2016 | -26.34M |
| December 31, 2015 | -25.77M |
| September 30, 2015 | -25.61M |
| June 30, 2015 | -27.83M |
| March 31, 2015 | -27.71M |
| December 31, 2014 | -9.754M |
| September 30, 2014 | -7.861M |
| June 30, 2014 | 148.42M |
| March 31, 2014 | 18.27M |
| December 31, 2013 | 13.02M |
| September 30, 2013 | 113.57M |
| June 30, 2013 | 23.39M |
| March 31, 2013 | 247.86M |
| December 31, 2012 | 6.72M |
| September 30, 2012 | 12.42M |
| June 30, 2012 | 214.26M |
| March 31, 2012 | 2.476M |
| December 31, 2011 | 2.851M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-414.26M
Minimum
Jun 2021
60.33M
Maximum
Mar 2022
-37.14M
Average
-10.78M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | 1.653M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 37.05M |
| Cash from Investing (Quarterly) | -43.04M |
| Free Cash Flow | 152.43M |
| Free Cash Flow Per Share (Quarterly) | 0.4383 |
| Free Cash Flow to Equity (Quarterly) | 36.52M |
| Free Cash Flow to Firm (Quarterly) | 38.22M |
| Free Cash Flow Yield | 11.81% |